Literature DB >> 9677385

Functional changes in scavenger receptor binding conformation are induced by charge mutants spanning the entire collagen domain.

L Andersson1, M W Freeman.   

Abstract

Macrophage scavenger receptors are trimeric integral membrane proteins that bind a diverse array of negatively charged ligands. They have been shown to play a role in the pathogenesis of atherosclerosis and in host responses to microbial infections. Earlier mutational studies demonstrated that the distal segment of the collagen domain of the receptor was critically important for high affinity ligand binding activity. In this study, mutations spanning the entire collagen domain were generated and binding was assayed in transfected cells, as well as in assays employing a secreted, receptor fusion protein. Many of the distal, positively charged C-terminal residues in the type II collagen domain of the receptor, previously reported to be essential for binding at 37 degreesC, were found not to be critical for binding at 4 degreesC. Conversely, more proximally charged residues of the collagen receptor that have not been previously mutated were shown to have substantial effects on binding that were also temperature-dependent. These data suggest that scavenger receptor ligand recognition depends on more complex conformational interactions, involving charged residues throughout the entire collagen domain, than was previously recognized.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677385     DOI: 10.1074/jbc.273.31.19592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.

Authors:  M Chen; S Narumiya; T Masaki; T Sawamura
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.

Authors:  N Platt; S Gordon
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 3.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

Review 4.  Class A1 scavenger receptors in cardiovascular diseases.

Authors:  Jingjing Ben; Xudong Zhu; Hanwen Zhang; Qi Chen
Journal:  Br J Pharmacol       Date:  2015-03-27       Impact factor: 8.739

5.  Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity.

Authors:  Monika Heilmann; Anne Wellner; Gabriele Gadermaier; Anne Ilchmann; Peter Briza; Maren Krause; Ryoji Nagai; Sven Burgdorf; Stephan Scheurer; Stefan Vieths; Thomas Henle; Masako Toda
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

6.  Direct detection of collagenous proteins by fluorescently labeled collagen mimetic peptides.

Authors:  Yang Li; Daniel Ho; Huan Meng; Tania R Chan; Bo An; Hanry Yu; Barbara Brodsky; Albert S Jun; S Michael Yu
Journal:  Bioconjug Chem       Date:  2013-01-03       Impact factor: 4.774

7.  Modified low density lipoproteins binding requires a lysine cluster region in the murine macrophage scavenger receptor class A type II.

Authors:  Francisco J Leyva; Mark A Pershouse; Andrij Holian
Journal:  Mol Biol Rep       Date:  2009-09-23       Impact factor: 2.316

8.  Quantitative and qualitative methods using fluorescence microscopy for the study of modified low density lipoproteins uptake.

Authors:  Francisco J Leyva; Mark A Pershouse
Journal:  Scanning       Date:  2009 Jul-Aug       Impact factor: 1.932

9.  Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.

Authors:  Nicole M Plourde; Sandhya Kortagere; William Welsh; Prabhas V Moghe
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

Review 10.  Silica binding and toxicity in alveolar macrophages.

Authors:  Raymond F Hamilton; Sheetal A Thakur; Andrij Holian
Journal:  Free Radic Biol Med       Date:  2007-12-27       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.